TSGA10: A Potential Drug Target for Skin and Bone Diseases (G80705)

Target Name: TSGA10

NCBI ID: G80705

TSGA10

TSGA10: A Potential Drug Target for Skin and Bone Diseases

TSGA10 (SPGF26) is a protein that is expressed in various tissues of the human body, including the skin, hair, nails, and bones. It is a member of the transforming growth factor family 2 (TGF-2) family, which plays a crucial role in cell growth, differentiation, and repair. TSGA10 has been shown to be involved in several biological processes, including skin development, wound healing, and bone growth.

TSGA10 has also been identified as a potential drug target or biomarker. Researchers have shown that TSGA10 can be targeted with small molecules, such as inhibitors, to inhibit its activity and prevent the development of certain diseases. This suggests that TSGA10 may be a useful target for the development of new treatments for a variety of conditions.

One of the potential benefits of targeting TSGA10 is its ability to stimulate the production of new cells in the skin. This can be useful for the development of treatments for skin diseases, such as acne, where the growth of new cells can help to remove the infected or damaged cells.

Another potential benefit of targeting TSGA10 is its role in wound healing. TSGA10 has been shown to promote the formation of new tissue in the wound, which can help to accelerate the healing process. This can be useful for the development of new treatments for wounds, such as diabetic foot ulcers or pressure sores.

TSGA10 has also been shown to be involved in the regulation of bone growth and development. This can be important for the development of treatments for bone diseases, such as osteoporosis.

In addition to its potential as a drug target, TSGA10 also has potential as a biomarker. Researchers have shown that the levels of TSGA10 in skin samples from individuals with certain skin diseases are higher than in individuals without the diseases. This suggests that TSGA10 may be a useful biomarker for the diagnosis and monitoring of skin diseases.

Overall, TSGA10 is a protein that has been shown to be involved in several important biological processes in the human body. Its potential as a drug target or biomarker makes it an attractive target for research into the development of new treatments for a variety of conditions. Further research is needed to fully understand the role of TSGA10 in these processes and to develop new treatments based on its activity.

Protein Name: Testis Specific 10

Functions: Plays a role in spermatogenesis (PubMed:28905369). When overexpressed, prevents nuclear localization of HIF1A (By similarity)

The "TSGA10 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about TSGA10 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets